Business

/

Meet Unbuzzd: A Drink Slated to Kill the Hangover

In the crowded wellness space, one company stands out with a product that promises to transform how we manage alcohol consumption. Quantum BioPharma, a biopharmaceutical firm known for tackling neurodegenerative and metabolic disorders, has made an intriguing pivot with the launch of Unbuzzd, an alcohol detox drink designed to help people recover quickly and effectively after drinking. Supported by high-profile investors and a strategic distribution network, Unbuzzd aims to reshape the burgeoning detox drink market.

Unlike traditional recovery drinks, which are typically aimed at alleviating the discomfort associated with hangovers, Unbuzzd targets alcohol metabolism directly. Developed by Quantum BioPharma’s R&D team, the drink is a proprietary blend of vitamins and minerals specifically designed to support liver and brain function. It helps users restore mental clarity and regain cognitive function within 15 to 30 minutes after drinking.

The drink is available in two formats: Ready-to-Mix (RTM) powder sticks, already on Amazon, and a soon-to-be-released Ready-to-Drink (RTD) 12oz can. This convenience factor is expected to appeal to a wide range of consumers, from busy professionals who must stay sharp after a night out to parents balancing family life after a celebratory drink.

According to Kevin Harrington, an early investor in Unbuzzd and an original shark on Shark Tank, the product “will change society.” He’s not alone in his belief—Unbuzzd is supported by a team of beverage industry veterans, including John Duffy, CEO of Celly Nutrition (a Quantum BioPharma subsidiary that holds the marketing rights for Unbuzzd), and Gerry David, former CEO of Celsius Holdings. Their combined expertise in launching and scaling successful beverage brands positions Unbuzzd for substantial growth in the health-conscious market.

The global market for detox drinks is experiencing rapid growth. It was valued at $5.36 billion in 2023 and is expected to reach $9.66 billion by 2032, with an annual growth rate of 6.95%. The increasing demand for products that promote quick recovery from alcohol is particularly notable during periods of high alcohol consumption, such as the holiday season.

Unbuzzd’s strategic timing couldn’t be better. As consumers become more health-conscious and look for ways to mitigate the negative effects of alcohol without compromising their lifestyles, the product is entering a space primed for expansion. Quantum BioPharma’s innovative approach allows Unbuzzd to stand out by not just easing hangover symptoms but actively accelerating the body’s alcohol metabolism.

Quantum BioPharma has also ensured its market presence through a strategic spin-off agreement with Celly Nutrition, maintaining a 25.71% stake in the company. Under this agreement, Quantum BioPharma receives a 7% royalty on Unbuzzd sales, which drops to 3% after the company reaches $250 million in total payments. This arrangement positions Quantum BioPharma to benefit financially as the product gains traction.

Unbuzzd’s potential is not limited to online retail. In October, Celly Nutrition signed a master distribution agreement with FUSION Consulting Group, a leading brand incubator and distributor of health-conscious food and beverages in Puerto Rico, the Caribbean, and Central and South America. This partnership will bring Unbuzzd to new markets, including vacation destinations where alcohol consumption is often part of the experience.

FUSION’s CEO, Eduardo Santacana, expressed his enthusiasm for the partnership, noting that Unbuzzd’s innovative formula addresses the growing demand for products that promote mental clarity and quick recovery after drinking. With major retail customers like Walmart, Walgreens, CVS, and Costco already in their portfolio, the partnership with FUSION opens vast new opportunities for Unbuzzd to penetrate the market.

One of Unbuzzd’s most compelling features is its focus on mental recovery. While most hangover products focus on physical symptoms like headaches or nausea, Unbuzzd addresses the cognitive effects of alcohol, helping users regain mental alertness and clarity. This makes it particularly appealing for individuals who want to stay sharp and productive after drinking.

As alcohol sales spike during the holiday season, products like Unbuzzd are poised to meet the demand from consumers who want to enjoy themselves without the lingering effects of alcohol. Its ability to help people recover faster and more effectively could shift how society views responsible drinking.

Kevin Harrington, with his extensive background in successful product launches, including Celsius’ influencer marketing program development, sees Unbuzzd as a game-changer. “For the drinker who needs to sit through a three-hour play after cocktails or for the parent who still must take their kids to school in the morning, Unbuzzd is making it possible to drink because it makes a quick recovery possible,” Harrington explains. His confidence in the product is backed by over $6 billion in global sales he has generated throughout his career.

The growing popularity of alcohol detox products is undeniable. The global market for hangover cure products was valued at $2 billion in 2022 and is expected to grow annually by 14.8% to reach $6.2 billion by 2030. In the U.S. alone, the hangover cure market was valued at $393.2 million in 2022, projected to hit $1.15 billion by 2030.

Unbuzzd is positioned to capitalize on this growing market, particularly as it continues to expand its product line. Plans are already in place to launch a 12oz can format in 2025, adding even more convenience for consumers seeking quick recovery after drinking.

Quantum BioPharma’s diversification strategy, spearheaded by its stake in Celly Nutrition, provides the company with multiple avenues for revenue generation. As Unbuzzd enters new markets and expands its product offerings, Quantum BioPharma benefits from the increased demand for alcohol detoxification products.

Unbuzzd isn’t just another hangover cure—it’s a game-changing product poised to revolutionize how we think about alcohol consumption and recovery. With its focus on mental clarity, rapid recovery, and convenient formats, Unbuzzd is carving out a niche in the growing detox drink market. Backed by industry veterans and supported by strategic partnerships, Quantum BioPharma’s innovative approach to alcohol detoxification could very well reshape the wellness industry.